Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LZM005 |
Synonyms | |
Therapy Description |
LZM005 is an ERBB2 (HER2)-targeted antibody with increased affinity for domain II, which may have antitumor activity (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 1042). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LZM005 | LZ-M005|LZ M005 | HER2 (ERBB2) Antibody 76 | LZM005 is an ERBB2 (HER2)-targeted antibody with increased affinity for domain II, which may have antitumor activity (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 1042). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|